SCHEMBL1991233

SCHEMBL1991233

CCCCOC(=O)N1CCN(C(C)(C)CO)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
LMNA P02545 1/20 0.55
HRH2 P25021 5/20 0.42
HRH1 P35367 5/20 0.42
ALDH1A1 P00352 4/20 0.38
HTT P42858 1/20 0.38
CYP3A4 P08684 2/20 0.38
SMYD3 Q9H7B4 1/20 0.38
GAA P10253 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
APP P05067 3/20 0.37
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
PLA2G2A P14555 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4698574 0.89 POLB (0.56) POLBSMN1; SMN2LMNAHRH2HRH1
SCHEMBL31288098 0.88 LMNA (0.49) POLBSMN1; SMN2LMNAHRH2HRH1
SCHEMBL15932258 0.86 POLB (0.59) POLBSMN1; SMN2LMNAHRH2HRH1
SCHEMBL9405372 0.83 POLB (0.73) POLBSMN1; SMN2LMNAHRH2HRH1
SCHEMBL953403 0.80 SMN1; SMN2 (0.59) POLBSMN1; SMN2LMNAHRH2HRH1
SCHEMBL24300560 0.77 CYP1A2 (0.44) SMN1; SMN2ALDH1A1CYP3A4APPPSEN1
SCHEMBL5594520 0.77 POLB (0.65) POLBSMN1; SMN2LMNAHRH2HRH1
SCHEMBL14590615 0.77 POLB (0.65) POLBSMN1; SMN2LMNAHRH2HRH1
SCHEMBL27826063 0.77 SMN1; SMN2 (0.65) POLBSMN1; SMN2LMNAHRH2HRH1
SCHEMBL5594524 0.77 POLB (0.65) POLBSMN1; SMN2LMNAHRH2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO POLB 3713/4885SMN1; SMN2 2548/4885LMNA 4319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.